相关实验视频

Updated: Jun 19, 2026

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats

Published on: April 15, 2016

肝细胞癌的局部区域治疗的最新进展

Anna Podlasek^1,2, Maheeba Abdulla³, Dieter Broering⁴

¹Tayside Innovation MedTech Ecosystem (TIME), University of Dundee, Dundee DD1 4HN, UK.

|July 14, 2023

概括

肝细胞癌 (HCC) 是一种不断增长的肝癌,越来越多地使用局部区域疗法来治疗. 本综述涵盖了HCC的射频切除,跨动脉化学栓塞和跨动脉放射栓塞的最新进展.

科学领域:

肝病学和瘤学肝病学和瘤学
干预性放射学干预性放射学

背景情况:

肝细胞癌 (HCC) 占初级肝癌的90%.
全球HCC的发病率,发病率和死亡率正在上升.
近几十年来,治疗方面取得了重大进展.

研究的目的:

总结最近在HCC的局部区域治疗方面取得的进展.
提供先进的HCC治疗方法的概述.

主要方法:

关于HCC局部区域治疗的当前文献的综述.
专注于三个主要方法:射频切除,跨动脉化学栓塞和跨动脉放射栓塞.

主要成果:

地方区域疗法在HCC管理中带来了一场革命.
详细介绍了射频剥离,TACE和TARE的具体进展.
这些方法代表了治疗原发性肝癌的关键进展.

结论:

在现代HCC治疗中,地方区域疗法是关键.
持续的研究正在推进这些肝癌干预措施的疗效.
这些方法为肝细胞癌患者提供了更好的结果.

关键词:

肝细胞癌是肝细胞癌.肝脏瘤是什么意思无线电频率剥离方式

更多相关视频

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...